During the last years, progress has been made on the identification of mechanisms involved in anterior pituitary cell transformation and tumorigenesis. Oncogene activation, tumor suppressor gene inactivation, epigenetic changes, and microRNAs deregulation contribute to the initiation of pituitary tumors. Despite the high prevalence of pituitary adenomas, they are mostly benign, indicating that intrinsic mechanisms may regulate pituitary cell expansion. Senescence is characterized by an irreversible cell cycle arrest and represents an important protective mechanism against malignancy. Pituitary tumor transforming gene (PTTG) is an oncogene involved in early stages of pituitary tumor development, and also triggers a senescence response by act...
OBJECTIVE: The model of "oncogene-induced senescence" (OIS), resulting in cell-proliferation arrest,...
Novel detrimental functions of senescent cells have been recently uncovered in the context of cancer...
In recent years the demonstration that human pituitary adenomas are monoclonal in origin provides fu...
Cytokines of the IL-6 or gp130 family regulate many cellular responses and play regulatory roles in ...
IL-6 is a pleiotropic cytokine with multiple pathophysiological functions. As a key factor of the se...
Pituitary tumors occur sporadically (95%) or as hereditary tumors, either associated with endocrine ...
Cellular senescence is a stable proliferative arrest state. Pituitary adenomas are frequent and most...
Although pituitary adenomas represent 25% of intracranial tumors, they are usually benign, with the ...
Pituitary tumors represent the most common intracranial neoplasms accompanying serious morbidity thr...
The anterior pituitary can develop benign tumors of different sizes, classified as micro- and macroa...
Substantial advances have been made recently in the pathobiology of pituitary tumors. Similar to man...
The pathogenesis of tumour formation in the anterior pituitary has been intensively studied, but the...
Oncogenes and tumor suppressor genes involved in most common cancers are not involved in the great m...
The molecular mechanisms underlying the capability of pituitary tumours to avoid unregulated cell pr...
F. Caimari was supported by the Fundación Alfonso Martin Escudero fellowship.Recently, a number of n...
OBJECTIVE: The model of "oncogene-induced senescence" (OIS), resulting in cell-proliferation arrest,...
Novel detrimental functions of senescent cells have been recently uncovered in the context of cancer...
In recent years the demonstration that human pituitary adenomas are monoclonal in origin provides fu...
Cytokines of the IL-6 or gp130 family regulate many cellular responses and play regulatory roles in ...
IL-6 is a pleiotropic cytokine with multiple pathophysiological functions. As a key factor of the se...
Pituitary tumors occur sporadically (95%) or as hereditary tumors, either associated with endocrine ...
Cellular senescence is a stable proliferative arrest state. Pituitary adenomas are frequent and most...
Although pituitary adenomas represent 25% of intracranial tumors, they are usually benign, with the ...
Pituitary tumors represent the most common intracranial neoplasms accompanying serious morbidity thr...
The anterior pituitary can develop benign tumors of different sizes, classified as micro- and macroa...
Substantial advances have been made recently in the pathobiology of pituitary tumors. Similar to man...
The pathogenesis of tumour formation in the anterior pituitary has been intensively studied, but the...
Oncogenes and tumor suppressor genes involved in most common cancers are not involved in the great m...
The molecular mechanisms underlying the capability of pituitary tumours to avoid unregulated cell pr...
F. Caimari was supported by the Fundación Alfonso Martin Escudero fellowship.Recently, a number of n...
OBJECTIVE: The model of "oncogene-induced senescence" (OIS), resulting in cell-proliferation arrest,...
Novel detrimental functions of senescent cells have been recently uncovered in the context of cancer...
In recent years the demonstration that human pituitary adenomas are monoclonal in origin provides fu...